Tesamorelin

26 minutesRx — Prescription
EgriftaTH9507

An FDA-approved GHRH analog used to reduce visceral adipose tissue in HIV-associated lipodystrophy.

FDA-approved prescription medication (Egrifta). Approved for HIV-associated lipodystrophy. Consult a healthcare provider.

Dosing Ranges

Conservative

Starting dose

12.5 mcg/kg

Standard (1.4 mg)

Standard dose

18.75 mcg/kg

High (2 mg)

Aggressive dose

25 mcg/kg

Doses are in mcg per kg of body weight. Use the Dosage Calculator to get your exact dose.

Protocol Details

Frequency

1x daily

Cycle Length

6–12 months (FDA protocol)

Administration

Subcutaneous injection

Research Notes

  • 1FDA-approved as Egrifta for HIV-related visceral fat accumulation.
  • 2Stimulates pulsatile GH release similar to endogenous GHRH.
  • 3Studied for reducing liver fat and improving body composition.
  • 4Requires medical supervision — prescription medication.

Common Vial Sizes

1 mg2 mg

Calculate your dose

Enter your body weight to get your exact dose in mcg for Tesamorelin.

Open Dosage Calculator

Where to source peptides

Research Use Only

For research use only. PepStack may earn a commission on purchases made through these links — at no extra cost to you.

For informational and research tracking purposes only. Not medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.

Sources & References

User Reviews

Loading reviews…

PepStack is for research and educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before using any peptides. Dosing data is sourced from published research and community protocols — verify with your provider.

View our sources →